Gynecologic Cancers (Record no. 5844)

MARC details
000 -LEADER
fixed length control field 01684nam a22002057a 4500
001 - CONTROL NUMBER
control field 20220304113954.0
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20240305192402.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 220304b |||||||| |||| 00| 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9789535172765
International Standard Book Number 953517276X
040 ## - CATALOGING SOURCE
Transcribing agency Data centre
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Samir A. Farghaly
9 (RLIN) 27980
245 ## - TITLE STATEMENT
Title Gynecologic Cancers
Remainder of title Basic Sciences, Clinical and Therapeutic Perspectives
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. London
Name of publisher, distributor, etc. IntechOpen
Date of publication, distribution, etc. 2016
300 ## - PHYSICAL DESCRIPTION
Extent 340 pages
520 ## - SUMMARY, ETC.
Summary, etc. Gynecologic cancers include malignancies of the female genital tract involving the vulva, vagina, cervix, uterus, fallopian tubes or ovaries. In the USA, 98,280 women had gynecological cancers in 2015, and 30,440 died of these cancers. World wide, the number of women who had cancers of the female genital tract was 1,085,900, in 2012 and the number of deaths was 417,600. Cancers of the uterus, cervix and ovary are most common. Widespread screening with the Pap test has allowed physicians to find per-cancerous changes in the cervix and vagina. This has assisted in identifying some invasive cancers early. Multidisciplinary team of experts includes specialists in medical oncology, gynecologic oncology, radiology, urology, radiotherapy, and surgery who work together to determine the best treatment approach for the patient. Recent progress in the development of new surgical techniques has transformed the treatment of gynecologic cancers, resulting in greater surgical precision and fewer complications. In addition targeted adjuvant therapy has become useful in improving the oncologic outcome of patients with these cancers.
600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME
General subdivision Oncology
9 (RLIN) 29434
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme ddc
Koha item type E-BOOKS
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Collection Home library Current library Shelving location Date acquired Total checkouts Full call number Barcode Date last seen Price effective from Koha item type
            MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO   03/04/2022   20220304113954.0 EBS10321 03/04/2022 03/04/2022 E-BOOKS
Catholic University of  Health and Allied Sciences - CUHAS
Directorate of ICT @ 2024